Zenopharm Zenopharm is a pharmaceutical company developing therapeutic solutions for the treatment of breast cancer. | ![]() Atossa Therapeutics Atossa Therapeutics (formerly Atossa Genetics) is a pharmaceutical company focused on the development of breast cancer therapeutics. | Briacell Briacell is a clinical-stage biotech company that focuses on immuno-oncology and develops personalized immunotherapy for cancer. | Venenum BioDesign Venenum BioDesign is a drug discovery company focused on discovering and advancing medicines for unmet medical needs in various therapeutic areas, including cancer, inflammation, infectious diseases, metabolic diseases, and women’s health. | |
Founding Date | Founding Date 2012 | Founding Date 2009 | Founding Date 2004 | Founding Date 2009 |
Type | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations HQ | Locations Seattle, US HQ Seattle, US | Locations West Vancouver, CA HQ Berkeley, US New York, US | Locations Trenton, US HQ |
Employees | Employees N/A | Employees 667% decrease | Employees 16 | Employees 26 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 182.3 m | Valuation ($) 30.2 m | Valuation ($) N/A |
Financial | ||||
Net income | Net income N/A | Net income ($34.8m) (FY, 2025) | Net income ($26.6m) (FY, 2025) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 18.3m | Total funding raised $ 7.6m | Total funding raised N/A | Total funding raised N/A |

Atossa Therapeutics (formerly Atossa Genetics) is a pharmaceutical company focused on the development of breast cancer therapeutics.
View companyBriacell is a clinical-stage biotech company that focuses on immuno-oncology and develops personalized immunotherapy for cancer.
View companyVenenum BioDesign is a drug discovery company focused on discovering and advancing medicines for unmet medical needs in various therapeutic areas, including cancer, inflammation, infectious diseases, metabolic diseases, and women’s health.
View company